Mixed results on the first generation of agents that target latent HIV infection lead experts to consider combination therapies and new assays.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Katsnelson, A. Setback prompts rethink of latency-reversing strategy to eliminate HIV infection. Nat Rev Drug Discov 13, 403–404 (2014). https://doi.org/10.1038/nrd4339
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4339